341
|
Koo S*, Sohn HS*, Kim TH*, Yang S, Jang SY, Ye S, Choi B, Kim SH, Park KS, Shin HM, Park OK, Kim C, Kang M, Soh M, Yoo J, Kim D, Lee N, Kim BS#, Jung Y#, Hyeon T#. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. Nature Nanotechnology 18: 1502-1514 (2023) 
|
340
|
Go S, Jung M, Lee S, Moon S, Hong J, Kim C, Chung Y, Kim BS. A personalized cancer nanovaccine that enhances T-cell responses and efficacy through dual Interactions with dendritic cells and T cells. Advanced Materials 2303979 (2023) 
|
339
|
Kuen DS*, Hong J*, Lee SY, Koh CH, Kim BS, Jung M, Kim YJ, Cho BS#, Kim BS#, Chung Y#. A personalized cancer vaccine that induces synergistic innate and adaptive immune responses. Advanced Materials 2303080 (2023) 
|
338
|
Moon S, Hong J, Go S, Kim BS. Immunomodulation for tissue repair and regeneration. Tissue Engineering and Regenerative Medicine 20, 389-409 (2023) |
337
|
Jung M, Kim H, Hwang JW, Choi Y, Kang M, Kim C, Hong J, Lee NK, Moon S, Chang JW, Choi SJ, Oh SY, Jang H, Na DL, Kim BS. Iron oxide nanoparticle-incorporated mesenchymal stem cells for Alzheimer’s disease treatment. Nano Letters 23(2):
|
336
|
Hong J, Jung M, Kim C, Kang M, Go S, Sohn H, Moon S, Kwon S, Song SY, Kim BS. Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine. Experimental & Molecular Medicine 55, 541-554 (2023)
|
1 
